{
}
UBS has upgraded its price target for Schott Pharma from €28.20 to €29.20 while maintaining a "buy" rating. The pharmaceutical supplier reported a strong quarter, although a cautious outlook for 2025 has tempered expectations, according to analyst Olivier Calvet.
UBS has increased its price target for GEA Group from €59 to €67 while maintaining a "Buy" rating. Analyst Sven Weier cited better-than-expected first-quarter results and raised order estimates for 2025 and 2026, surpassing consensus expectations, driven by strong order momentum.
UBS has increased its price target for Gea Group from 59 to 67 euros while maintaining a "Buy" rating. Analyst Sven Weier cited better-than-expected first-quarter results and raised order estimates for 2025 and 2026, surpassing consensus expectations, with order momentum being a key factor in this optimistic outlook.
UBS has maintained a buy recommendation for GEA, raising its price target from €59 to €67, indicating a potential upside of 17%. The company anticipates organic sales growth of over 5% annually until 2030, with EBITDA growth projected between 17% and 19%, and a return on capital employed exceeding 45%.
In a recent podcast, financial journalists discussed a record DAX performance, overpriced whiskey, and Ryanair's rally, alongside insights on major companies like Volkswagen, Mercedes, and Lufthansa. They highlighted the positive quarterly results from over 60% of DAX companies and upcoming Annual General Meetings for firms such as Symrise and Porsche. The conversation also touched on various market trends and investment risks, emphasizing the volatility of stocks and leveraged products.
Barclays has upgraded Aedifica to 'overweight' from 'underweight', supporting its return to a growth strategy. The brokerage raised its 5-year EPS growth forecast to 0.9% and increased the price target by 23% to EUR 74, citing potential benefits from a merger with Cofinimmo. Out of 15 analysts, nine recommend the stock as a "strong buy" or "buy."
Allianz shares dropped to EUR 338.10 last week but found stability near the 50-day moving average, which serves as a crucial support level. Despite the company reporting record figures for the past quarter, the share price weakness remains evident, highlighting an intriguing technical situation.
UBS is offering pensioners 90% compensation for losses incurred from risky currency products, a surprising move for the bank. Clients, including a pensioner who lost nearly half a million, were not adequately warned about the dangers of these investments, leading to significant financial distress. This offer aims to mitigate potential court cases stemming from the bank's lack of due diligence in selling these high-risk products to retail clients.
Raiffeisen Bank shares show signs of stabilization after turbulent months, with a recent 1.83% rise to EUR 26.70, marking a 40% increase this year. However, challenges remain, including interest rate uncertainty and geopolitical risks, particularly in Eastern Europe, which presents both growth potential and volatility. Investors are advised to weigh the risks and opportunities as management navigates these conditions.
Deutsche Bank has raised its price target for Unicredit shares to EUR61.50 from EUR50.60, maintaining a Hold rating. This adjustment reflects Unicredit's strong financial performance, with projected net income exceeding EUR9.3 billion by 2025, achieved without major mergers or acquisitions. The bank's effective balance between declining net interest income and growing commission revenues has been highlighted, supported by insights from discussions with Unicredit's leadership.
Euro
Currency
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
UBS raises Schott Pharma price target to 29.20 euros maintains buy rating
13:54 20.05.2025
ubs raises gea group price target to 67 euros maintains buy rating
13:50 20.05.2025
ubs raises gea group price target to 67 euros maintains buy rating
12:37 20.05.2025
ubs raises price target for gea amid positive growth outlook
11:01 20.05.2025
financial insights on market trends and corporate developments in germany
Euro
Rheinmetall AG
Rivian Automotive Inc.
Nvidia Corporation
Regeneron Pharmaceuticals Inc.
Salzgitter AG
VOLKSWAGEN AG
Xiaomi Corporation
Ferrari N.V.
Renk AG
Mercedes-Benz AG
KOR
DEU
Christoph Kapalschinski
Nando Sommerfeldt
Donald Trump
Show more
09:08 20.05.2025
Barclays upgrades Aedifica to overweight citing growth strategy and acquisitions
08:41 20.05.2025
Allianz shares stabilize as technical support holds despite record figures
08:19 20.05.2025
ubs offers 90 percent compensation to pensioners amid dollar scandal
07:50 20.05.2025
Raiffeisen Bank shares show signs of stabilization amid ongoing challenges
20:20 19.05.2025
Deutsche Bank raises Unicredit stock target to 61.50 euros amid strong growth
18:45 19.05.2025
Trending
Subcategory
Stock Market Updates
Market Analysis and Predictions
Banking Regulations
Finance Mergers & Acquisitions
Corporate Responsibility & ESG
Corporate News
Industry Trends
AI Innovations
Product Launches
Swiss Financial Market Supervisory Authority
Hedge Funds & Private Equity
Government Policies
Retail and Consumer Goods
Global Financial Events
Software Development Trends
AI Ethics & Policy
Employment Reports
AI Applications
Domestic Politics
Venture Capital Investments
Countries:
Companies:
UBS Group AG
Raiffeisen Bank International AG
Huawei Technologies CO. Ltd.
Credit Suisse Group Ltd.
Microsoft Corporation Corp.
Nvidia Corporation
Wells Fargo & Company
Apple Inc.
Alphabet Inc.
DEUTSCHE BANK AG
GEA Group AG
Bank of America Corp.
Norges Bank
The Goldman Sachs Group, Inc.
Hindustan Aeronautics Ltd.
Tesla Inc.
Swiss Life, Agence générale Canton de Fribourg, Daniel Piller, Agent Général
Banco BPM S.p.A.
Xiaomi Corporation
UBS GROUP B.V.
Currencies:
United States Dollar
Swiss Franc
Euro
Chinese Yuan
British Pound Sterling
New Zealand Dollar
Japanese Yen
Hong Kong Dollar
People: